Main Menu

News and features 

Read the latest stories about our world-leading research, science, fundraising and philanthropy. 

To find out more, you can contact our media team, follow us on social media or visit our press release archive.


Sign up for our newsletters


News

Scientists can predict how long prostate cancer patients will respond to olaparib 21
Nov
2024

Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP inhibitor drug, olaparib, according to new research published in the journal Cancer Cell. Find out more

New potential cancer-driving genes unveiled, opening new paths for precision treatments 19
Nov
2024

Researchers have carried out an in-depth analysis of 10,478 cancer genomes across 35 different cancer types, identifying 330 potential cancer-driving genes, 74 of which are newly associated with cancer. The findings highlight the potential to develop new, more targeted treatment options for cancer patients. Find out more

Mobile ‘Man Van’ spots prostate cancer more quickly and cheaply than via GPs 16
Nov
2024

Mobile testing ‘Man Van’ can diagnose prostate cancer in at-risk groups earlier and more affordably than GPs, according to new research. Find out more

See all news articles

Features

Scientific achievements of 2023 05
Dec
2023

We've selected a range of discoveries from the academic year that highlight the quality and breadth of our basic, translational and clinical research. Find out more

Untapping the full potential of immunotherapies for more people with cancer 06
Jun
2023

Immunotherapy works by sparking the body’s own immune system into action against tumours. It has become a first-choice treatment for some types of cancer, and now there are exciting opportunities to unlock its benefits for more patients through research. Jane Shepley explores the story behind immunotherapy and how we can untap its potential. Find out more

Over a decade of abiraterone: the drug that revolutionised advanced prostate cancer care 14
Mar
2023

This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. We share the story of the drug’s discovery, how a landmark trial changed the way advanced prostate cancer is treated today, and what the drug has meant for patients who are currently treated with it. Find out more

See all feature articles